The Europe Insulin Syringes Market would witness market growth of 3.7% CAGR during the forecast period (2021-2027).
The World Health Organization (WHO) wants to encourage and promote the implementation of efficient diabetes monitoring, preventive, and control methods, especially in low- and middle countries. WHO accomplishes this by developing scientific regarding the prevention of major noncommunicable diseases, such as diabetes; developing norms and standards for diabetes care and diagnosis; raising awareness of the global diabetes epidemic by commemorating World Diabetes Day (November 14); and conducting diabetes and risk factor surveillance.
Due to the surge in diabetes cases, companies are launching insulin syringes on a massive scale. For example, Abbott and Novo Nordisk today announced a non-exclusive cooperation to incorporate insulin dosage data from Novo Nordisk pre-filled and durable linked pens straight into digital health solutions compatible with the FreeStyle Libre system on February 20, 2019. Both firms are committed to making diabetes care easier by linking important technologies like continuous glucose monitoring (CGM) and linked insulin pens.
Diabetes is becoming more common among people of all ages in Europe, owing to rising rates of overweight and obesity, poor food, and physical inactivity. Cardiovascular illness (mainly heart disease and stroke) kills 50 percent of diabetics, whereas kidney failure kills 10-20 percent of diabetics. In the European Region, around 60 million individuals have diabetes, accounting for 10.3 percent of men and 9.6 percent of women aged 25 and above.
The Germany market dominated the Europe Insulin Syringes Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $137.9 million by 2027. The UK market would showcase a CAGR of 2.9% during (2021 - 2027). Additionally, The France market is expected to witness a CAGR of 4.5% during (2021 - 2027).
Based on Disease, the market is segmented into Type 2 Diabetes and Type 1 Diabetes. Based on Syringe Size, the market is segmented into 3/10 CC Syringe (0.3ml), 1/2 CC Syringe (0.5ml), 1CC Syringe (1ml) and Others. Based on End User, the market is segmented into Hospitals & Clinics, Homecare Settings, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Insulin Syringes Market Size will Hit $2.1 Billion by 2027, at a CAGR of 4.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Hindustan Syringes & Medical Devices Ltd., Novo Nordisk A/S, Biocon Limited, Eli Lilly and Company, Abbott Laboratories, Becton, Dickinson and Company, Cardinal Health, Inc., Medline Industries, Inc., Terumo Corporation, and Nipro Corporation.
Scope of the Study
Market Segments Covered in the Report:
By Disease
- Type 2 Diabetes and
- Type 1 Diabetes
By Syringe Size
- 3/10 CC Syringe (0.3ml)
- 1/2 CC Syringe (0.5ml)
- 1CC Syringe (1ml) and
- Others
By End User
- Hospitals & Clinics
- Homecare Settings, and
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Hindustan Syringes & Medical Devices Ltd.
- Novo Nordisk A/S
- Biocon Limited
- Eli Lilly and Company
- Abbott Laboratories
- Becton, Dickinson and Company
- Cardinal Health, Inc.
- Medline Industries, Inc.
- Terumo Corporation
- Nipro Corporation
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Insulin Syringes Market, by Disease
1.4.2 Europe Insulin Syringes Market, by Syringe Size
1.4.3 Europe Insulin Syringes Market, by End User
1.4.4 Europe Insulin Syringes Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Insulin Syringes Market by Disease
3.1 Europe Type 2 Diabetes Market by Country
3.2 Europe Type 1 Diabetes Market by Country
Chapter 4. Europe Insulin Syringes Market by Syringe Size
4.1 Europe 3/10 CC Syringe (0.3ml) Market by Country
4.2 Europe 1/2 CC Syringe (0.5ml) Market by Country
4.3 Europe 1CC Syringe (1ml) Market by Country
4.4 Europe Other Syringe Size Market by Country
Chapter 5. Europe Insulin Syringes Market by End User
5.1 Europe Hospitals & Clinics Market by Country
5.2 Europe Homecare Settings Market by Country
5.3 Europe Others Market by Country
Chapter 6. Europe Insulin Syringes Market by Country
6.1 Germany Insulin Syringes Market
6.1.1 Germany Insulin Syringes Market by Disease
6.1.2 Germany Insulin Syringes Market by Syringe Size
6.1.3 Germany Insulin Syringes Market by End User
6.2 UK Insulin Syringes Market
6.2.1 UK Insulin Syringes Market by Disease
6.2.2 UK Insulin Syringes Market by Syringe Size
6.2.3 UK Insulin Syringes Market by End User
6.3 France Insulin Syringes Market
6.3.1 France Insulin Syringes Market by Disease
6.3.2 France Insulin Syringes Market by Syringe Size
6.3.3 France Insulin Syringes Market by End User
6.4 Russia Insulin Syringes Market
6.4.1 Russia Insulin Syringes Market by Disease
6.4.2 Russia Insulin Syringes Market by Syringe Size
6.4.3 Russia Insulin Syringes Market by End User
6.5 Spain Insulin Syringes Market
6.5.1 Spain Insulin Syringes Market by Disease
6.5.2 Spain Insulin Syringes Market by Syringe Size
6.5.3 Spain Insulin Syringes Market by End User
6.6 Italy Insulin Syringes Market
6.6.1 Italy Insulin Syringes Market by Disease
6.6.2 Italy Insulin Syringes Market by Syringe Size
6.6.3 Italy Insulin Syringes Market by End User
6.7 Rest of Europe Insulin Syringes Market
6.7.1 Rest of Europe Insulin Syringes Market by Disease
6.7.2 Rest of Europe Insulin Syringes Market by Syringe Size
6.7.3 Rest of Europe Insulin Syringes Market by End User
Chapter 7. Company Profiles
7.1 Hindustan Syringes & Medical Devices Ltd.
7.1.1 Company Overview
7.2 Novo Nordisk A/S
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental & Regional Analysis
7.2.4 Research & Development Expenses
7.2.1 Recent strategies and developments:
7.2.1.1 Acquisitions and Mergers:
7.3 Biocon Limited
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.4 Eli Lilly and Company
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent Strategies and Developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.4.5.2 Product Launches and Product Expansions:
7.4.5.3 Approvals and Trials:
7.5 Abbott Laboratories
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.6 Becton, Dickinson and Company
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Approvals and Trials:
7.9 Terumo Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental Analysis
7.10. Nipro Corporation
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expenses
TABLE 1 Europe Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 2 Europe Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 3 Europe Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 4 Europe Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 5 Europe Type 2 Diabetes Market by Country, 2017 - 2020, USD Million
TABLE 6 Europe Type 2 Diabetes Market by Country, 2021 - 2027, USD Million
TABLE 7 Europe Type 1 Diabetes Market by Country, 2017 - 2020, USD Million
TABLE 8 Europe Type 1 Diabetes Market by Country, 2021 - 2027, USD Million
TABLE 9 Europe Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 10 Europe Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 11 Europe 3/10 CC Syringe (0.3ml) Market by Country, 2017 - 2020, USD Million
TABLE 12 Europe 3/10 CC Syringe (0.3ml) Market by Country, 2021 - 2027, USD Million
TABLE 13 Europe 1/2 CC Syringe (0.5ml) Market by Country, 2017 - 2020, USD Million
TABLE 14 Europe 1/2 CC Syringe (0.5ml) Market by Country, 2021 - 2027, USD Million
TABLE 15 Europe 1CC Syringe (1ml) Market by Country, 2017 - 2020, USD Million
TABLE 16 Europe 1CC Syringe (1ml) Market by Country, 2021 - 2027, USD Million
TABLE 17 Europe Other Syringe Size Market by Country, 2017 - 2020, USD Million
TABLE 18 Europe Other Syringe Size Market by Country, 2021 - 2027, USD Million
TABLE 19 Europe Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 20 Europe Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 21 Europe Hospitals & Clinics Market by Country, 2017 - 2020, USD Million
TABLE 22 Europe Hospitals & Clinics Market by Country, 2021 - 2027, USD Million
TABLE 23 Europe Homecare Settings Market by Country, 2017 - 2020, USD Million
TABLE 24 Europe Homecare Settings Market by Country, 2021 - 2027, USD Million
TABLE 25 Europe Others Market by Country, 2017 - 2020, USD Million
TABLE 26 Europe Others Market by Country, 2021 - 2027, USD Million
TABLE 27 Europe Insulin Syringes Market by Country, 2017 - 2020, USD Million
TABLE 28 Europe Insulin Syringes Market by Country, 2021 - 2027, USD Million
TABLE 29 Germany Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 30 Germany Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 31 Germany Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 32 Germany Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 33 Germany Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 34 Germany Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 35 Germany Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 36 Germany Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 37 UK Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 38 UK Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 39 UK Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 40 UK Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 41 UK Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 42 UK Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 43 UK Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 44 UK Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 45 France Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 46 France Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 47 France Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 48 France Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 49 France Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 50 France Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 51 France Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 52 France Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 53 Russia Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 54 Russia Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 55 Russia Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 56 Russia Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 57 Russia Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 58 Russia Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 59 Russia Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 60 Russia Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 61 Spain Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 62 Spain Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 63 Spain Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 64 Spain Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 65 Spain Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 66 Spain Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 67 Spain Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 68 Spain Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 69 Italy Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 70 Italy Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 71 Italy Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 72 Italy Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 73 Italy Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 74 Italy Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 75 Italy Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 76 Italy Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 77 Rest of Europe Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 78 Rest of Europe Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 79 Rest of Europe Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 80 Rest of Europe Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 81 Rest of Europe Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 82 Rest of Europe Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 83 Rest of Europe Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 84 Rest of Europe Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 85 Key Information – Hindustan Syringes & Medical Devices Ltd.
TABLE 86 Key information – Novo Nordisk A/S
TABLE 87 Key Information – Biocon Limited
TABLE 88 Key Information – Eli Lilly and Company
TABLE 89 Key Information – Abbott Laboratories
TABLE 90 Key information – Becton, Dickinson and Company
TABLE 91 key information – Cardinal Health, Inc.
TABLE 92 Key Information – Medline Industries, Inc.
TABLE 93 Key Information – Terumo Corporation
TABLE 94 Key Information – Nipro Corporation
List of Figures
FIG 1 Methodology for the research